Gibson Wealth Advisors’s Avanos Medical AVNS Stock Holding History

Gibson Wealth Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$2K	Buy	63 +62	+6,200%	+$1.52K	﹤0.01%	120
2022 Q3	$0	Hold	1	–	–	﹤0.01%	111
2022 Q2	$0	Hold	1	–	–	﹤0.01%	111
2022 Q1	$0	Hold	1	–	–	﹤0.01%	118
2021 Q4	$0	Buy	+1	New	+$32	﹤0.01%	102

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Gibson Wealth Advisors's AVNS Position: Q4 2022 in Review

Gibson Wealth Advisors increased its Avanos Medical (AVNS) stake by 6,200% in Q4 2022, buying an estimated $1.52K and bringing the position to 63 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #120.

Gibson Wealth Advisors first reported a position in AVNS in Q4 2021 and has held it in 5 quarters since. 288 funds tracked by Wall St. Rank hold AVNS as of Q4 2022.

Gibson Wealth Advisors held 63 shares of Avanos Medical worth $2K as of Q4 2022.
Gibson Wealth Advisors bought 62 Avanos Medical shares in Q4 2022, an estimated $1.52K.
Avanos Medical made up ﹤0.01% of Gibson Wealth Advisors's portfolio in Q4 2022, its #120 holding.
Gibson Wealth Advisors first reported a position in Avanos Medical in Q4 2021 and has held it in 5 quarters since.
288 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2022.

Based on Gibson Wealth Advisors's 13F filing for Q4 2022, filed 8 Feb 2023.